Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. JW (Cayman) Therapeutics Co. Ltd
  6. Financials
    2126   KYG5210T1040

JW (CAYMAN) THERAPEUTICS CO. LTD

(2126)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023
Capitalization1 8 6034 353--
Entreprise Value (EV)2 6 0852 4562 2113 123
P/E ratio -1,76x-7,79x-6,62x-8,03x
Yield ----
Capitalization / Revenue -42,5x12,4x5,08x
EV / Revenue -24,0x6,32x3,64x
EV / EBITDA -14,6x-4,81x-4,80x-6,94x
Price to Book -1,45x1,84x2,21x
Nbr of stocks (in thousands) 387 906406 656--
Reference price (CNY) 22,210,710,710,7
Announcement Date 03/26/2021---
1 HKD in Million
2 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023
Net sales1 --103350857
EBITDA1 --417-511-460-450
Operating profit (EBIT)1 --441-575-526-310
Operating Margin ---561%-151%-36,2%
Pre-Tax Profit (EBT)1 --1 664-629-526-412
Net income1 -633-1 664-629-526-412
Net margin ---613%-150%-48,1%
EPS2 -9,74-12,6-1,38-1,62-1,33
Dividend per Share2 -----
Announcement Date 10/21/202003/26/2021---
1 CNY in Million
2 CNY
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 S2 2021 S1 2021 S2
Net sales1 ---
EBITDA ---
Operating profit (EBIT)1 --337-313
Operating Margin ---
Pre-Tax Profit (EBT) ---
Net income ---
Net margin ---
EPS2 --0,71-0,78
Dividend per Share ---
Announcement Date 03/26/202108/27/2021-
1 CNY in Million
2 CNY
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt1 -----
Net Cash position1 -2 5181 8972 1431 231
Leverage (Debt / EBITDA) -6,03x3,71x4,65x2,74x
Free Cash Flow1 --391-1 011-496-656
ROE (Net Profit / Equities) --134%-16,6%-18,5%-28,6%
Shareholders' equity1 -1 2443 7952 8411 442
ROA (Net Profit / Asset) --74,8%-19,2%-15,1%-
Assets1 -2 2243 2763 474-
Book Value Per Share2 --7,375,804,85
Cash Flow per Share2 --1,98-1,79-1,57-
Capex1 -130210185185
Capex / Sales --205%52,9%21,6%
Announcement Date 10/21/202003/26/2021---
1 CNY in Million
2 CNY
Key data
Capitalization (HKD) 5 310 922 423
Capitalization (USD) 680 964 317
Net sales (CNY) 1 322 000
Net sales (USD) 207 123
Number of employees 477
Sales / Employee (CNY) 2 771
Sales / Employee (USD) 434
Free-Float 56,1%
Free-Float capitalization (HKD) 2 981 645 969
Free-Float capitalization (USD) 382 305 436
Avg. Exchange 20 sessions (CNY) 44 406 299
Avg. Exchange 20 sessions (USD) 6 957 312
Average Daily Capital Traded 0,84%
EPS & Dividend